Clinical Trials Browser

Phase 2/3 × combretastatin × Head & Neck × Clear all

NCT00507429 2014-06-09

FACT

Phase 2/3 Terminated

80 enrolled 10 charts

EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic